<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-11-29">29 November 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Joachim</forename><surname>Seegers</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<address>
									<addrLine>University Medical Center Go ¨ttingen, Robert-Koch-Str. 40, Go ¨ttingen 37075</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><surname>Conen</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University Hospital</orgName>
								<address>
									<settlement>Basel</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Klaus</forename><surname>Jung</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Medical Statistics</orgName>
								<address>
									<addrLine>University Medical Center Go ¨ttingen, Go ¨ttingen</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Leonard</forename><surname>Bergau</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<address>
									<addrLine>University Medical Center Go ¨ttingen, Robert-Koch-Str. 40, Go ¨ttingen 37075</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marc</forename><surname>Dorenkamp</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Charite ´Campus Virchow Klinikum</orgName>
								<address>
									<settlement>Cardiology Division, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lars</forename><surname>Lu ¨thje</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<address>
									<addrLine>University Medical Center Go ¨ttingen, Robert-Koch-Str. 40, Go ¨ttingen 37075</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Sohns</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<address>
									<addrLine>University Medical Center Go ¨ttingen, Robert-Koch-Str. 40, Go ¨ttingen 37075</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Samuel</forename><forename type="middle">T</forename><surname>Sossalla</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<address>
									<addrLine>University Medical Center Go ¨ttingen, Robert-Koch-Str. 40, Go ¨ttingen 37075</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="laboratory">DZHK (German Centre for Cardiovascular Research)</orgName>
								<address>
									<addrLine>Partner Site Go ¨ttingen, Go ¨ttingen</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><forename type="middle">H</forename><surname>Fischer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<address>
									<addrLine>University Medical Center Go ¨ttingen, Robert-Koch-Str. 40, Go ¨ttingen 37075</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="laboratory">DZHK (German Centre for Cardiovascular Research)</orgName>
								<address>
									<addrLine>Partner Site Go ¨ttingen, Go ¨ttingen</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gerd</forename><surname>Hasenfuss</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<address>
									<addrLine>University Medical Center Go ¨ttingen, Robert-Koch-Str. 40, Go ¨ttingen 37075</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="laboratory">DZHK (German Centre for Cardiovascular Research)</orgName>
								<address>
									<addrLine>Partner Site Go ¨ttingen, Go ¨ttingen</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tim</forename><surname>Friede</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Medical Statistics</orgName>
								<address>
									<addrLine>University Medical Center Go ¨ttingen, Go ¨ttingen</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="laboratory">DZHK (German Centre for Cardiovascular Research)</orgName>
								<address>
									<addrLine>Partner Site Go ¨ttingen, Go ¨ttingen</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Markus</forename><surname>Zabel</surname></persName>
							<email>markus.zabel@med.uni-goettingen.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<address>
									<addrLine>University Medical Center Go ¨ttingen, Robert-Koch-Str. 40, Go ¨ttingen 37075</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="laboratory">DZHK (German Centre for Cardiovascular Research)</orgName>
								<address>
									<addrLine>Partner Site Go ¨ttingen, Go ¨ttingen</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-11-29">29 November 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">E9CDD66916CADEF8EF282B59B830A987</idno>
					<idno type="DOI">10.1093/europace/euv361</idno>
					<note type="submission">Received 16 April 2015; accepted after revision</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Cardiovascular mortality † Risk factors † Implantable cardioverter-defibrillator † Sex difference † Sudden cardiac death</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Implantable cardioverter-defibrillators (ICDs) have been shown to improve survival, although a considerable number of patients never receive therapy.</s><s>Implantable cardioverter-defibrillators are routinely implanted regardless of sex.</s><s>There is continuing controversy whether major outcomes differ between men and women.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods and results</head><p><s>In this retrospective single-centre study, 1151 consecutive patients (19% women) undergoing ICD implantation between 1998 and 2010 were followed for mortality and first appropriate ICD shock over 4.9 + 2.7 years.</s><s>Sex-related differences were investigated using multivariable Cox models adjusting for potential confounders.</s><s>During follow-up, 318 patients died, a rate of 5.9% per year among men and 4.6% among women (uncorrected P ¼ 0.08); 266 patients received a first appropriate ICD shock (6.3% per year among men vs. 3.6% among women, P ¼ 0.002).</s><s>After multivariate correction, independent predictors of all-cause mortality were age (hazard ratio, HR ¼ 1.04 per year of age, 95% confidence interval (CI) [1.03 -1.06], P , 0.001), left ventricular ejection fraction (HR ¼ 0.98 per %, 95% CI [0.97-1.00],</s><s>P ¼ 0.025), renal function (HR ¼ 0.99 per mL/min/1.73</s><s>m 2 , 95% CI [0.99 -1.00], P ¼ 0.009), use of diuretics (HR ¼ 1.81, 95% CI [1.29-2.54],</s><s>P ¼ 0.0023), peripheral arterial disease (HR ¼ 2.21, 95% CI [1.62-3.00],</s><s>P , 0.001), and chronic obstructive pulmonary disease (HR ¼ 1.48, 95% CI [1.13 -1.94], P ¼ 0.029), but not sex.</s><s>Female sex (HR ¼ 0.51, 95% CI [0.33-0.81],</s><s>P ¼ 0.013), older age (HR ¼ 0.98, 95% CI [0.97-0.99],</s><s>P , 0.001), and primary prophylactic ICD indication (HR ¼ 0.69, 95% CI [0.52 -0.93], P ¼ 0.043) were independent predictors for less appropriate shocks.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>Women receive 50% less appropriate shocks than men having similar mortality in this large single-centre population.</s><s>These data may pertain to individually improved selection of defibrillator candidates using risk factors, e.g.</s><s>sex as demonstrated in this study.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Implantable cardioverter-defibrillators (ICDs) have been shown to improve survival <ref type="bibr">1 -4</ref> and current guidelines recommend their use for primary and secondary preventions of sudden cardiac death (SCD).</s><s>A large number of patients never receive appropriate therapy from their device, thus on an individual basis have not derived benefit. <ref type="bibr" target="#b4">5</ref></s><s>his may be explained by a lower all-cause and arrhythmic mortality, lower risk of life-threatening arrhythmias <ref type="bibr" target="#b5">6</ref> despite significant mortality, or with risk of death competing with risk of shock in patients with high mortality. <ref type="bibr" target="#b6">7</ref></s><s>omen are an important patient subgroup on whom controversial results have been reported regarding their ICD mortality benefit.</s><s>Smaller treatment benefit for women was reported in the original SCD in Heart Failure Trial publication <ref type="bibr" target="#b3">4</ref> -although not a specified subgroup-with a non-significant hazard ratio (HR) vs. placebo (HR ¼ 0.96 [0.56 -1.61], when compared with HR ¼ 0.73 [0.57-0.93]</s><s>for men).</s><s>Subsequent analyses showed that similar sexrelated differences of primary prevention mortality benefit were seen but could not be proved statistically as a factor interacting with ICD therapy. <ref type="bibr">8 -10</ref></s><s>Recent registry data revealed that appropriate ICD shocks were ≈30% lower in women in the first year after ICD implantation. <ref type="bibr" target="#b10">11</ref></s><s>Van der Heijden et al. <ref type="bibr" target="#b11">12</ref> found lower mortality for women but no difference in appropriate ICD therapy.</s><s>Therefore, the exact influence of sex on ICD therapy is yet unclear.</s></p><p><s>The aim of this retrospective study was to further investigate sex differences of all-cause mortality, death without prior shock, and appropriate ICD shock in a large single-centre population with longterm follow-up while correcting for a large number of possible confounders.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods Patients</head><p><s>Consecutive patients undergoing ICD or cardiac resynchronization therapy with defibrillator (CRT-D) implantation between 1998 and 2010 at our institution for guideline recommended indications were recorded in a retrospective single-centre ICD registry.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Baseline characteristics</head><p><s>Baseline characteristics were retrieved from hospital records, among them, age, sex, body mass index, systolic blood pressure, ischaemic or non-ischaemic disease, primary or secondary prophylactic defibrillator indication, New York Heart Association (NYHA) functional class, echocardiographic left ventricular ejection fraction (LVEF), cardiovascular drug treatment, and co-morbidities.</s><s>In addition, serum creatinine at What's new? † This study shows for the first time that women receive 50% less appropriate shocks than men over long-term follow-up in a large single-centre ICD patient population, and after adjustment for possible confounders.</s><s>† At the same time, they have a similar risk of all-cause mortality after adjustment.</s><s>† Annual mortality in this study was 5.9% per year among men and 4.6% among women.</s><s>† Annual rate of first appropriate ICD shock was 6.3% per year among men vs.  <ref type="bibr" target="#b12">13</ref> Underlying rhythm, heart rate, QRS, and uncorrected QT duration were taken from the admission electrocardiogram.</s><s>outside patient data and contacting patients was approved by the local ethics committee.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Device programming and interrogation</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Baseline characteristics are presented as mean + SD for continuous variables and as proportions for categorical variables.</s><s>Continuous variables are compared by Student's t-test; categorical variables by Pearson's x 2 test.</s><s>Predictors of mortality and appropriate ICD shocks were analysed in univariate and multivariate Cox proportional hazards regression models.</s><s>For appropriate ICD shocks, death was regarded as a competing risk. <ref type="bibr" target="#b13">14</ref></s><s>For all models, missing values were imputed by chained equations <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16</ref> as recently applied in a heart failure study. <ref type="bibr" target="#b16">17</ref></s><s>Forward variable selection was used to obtain the final multivariable model using a P-value of ,0.05 for inclusion of a given variable.</s><s>Sex category was entered into the multivariate models regardless of P-value.</s><s>To adjust for a nonproportional effect in the date of implantation, patients were stratified into three equally sized groups according to their dates of implantation, and stratified Cox regression was performed. <ref type="bibr" target="#b17">18</ref></s><s>Survival rates are illustrated by Kaplan-Meier curves.</s></p><p><s>Multivariable Cox models were built using the software R (version 3.0, www.r-project.org),</s><s>competing risk models were implemented using the R-package 'cmprsk'.</s><s>Missing values imputation was done with the R-package 'mice' using the default setting.</s><s>All other statistical analyses were performed using SPSS (version 21.0,</s><s>IBM Corporation).</s><s>For all tests, a P-value of ,0.05 was required for statistical significance.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patient characteristics</head><p><s>The data set included 1151 patients, among them 216 (19%) females.</s><s>Mean age was 64 + 13 years.</s><s>Implantable cardioverterdefibrillator therapy was prescribed for primary prophylaxis of SCD to 632 (55%) patients, and for secondary prophylaxis to 519 (45%) patients, respectively.</s><s>Of the latter, 236 of 519 (45%) were successfully resuscitated from cardiac arrest due to VF, the remaining 283 (55%) had a history of sustained symptomatic VT.</s><s>A single-chamber ICD was implanted in 375 (33%) patients, 375 (33%) received dual-chamber ICDs, and 401 (34%) a CRT-D.</s><s>Other baseline characteristics stratified by sex are presented in Table <ref type="table" target="#tab_0">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Long-term follow-up for mortality</head><p><s>All-cause mortality Overall follow-up was 4.9 + 2.7 years (maximum 14.0 years), 318 (27.6%) patients died corresponding to an annualized mortality rate of 5.6% in all patients, 5.9% among men, and 4.6% among women.</s><s>Uncorrected all-cause mortality in women was slightly lower (uncorrected P ¼ 0.08).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mortality without appropriate shock</head><p><s>Eighty-four (26.4%) of 318 deceased patients received at least one appropriate ICD shock, 234 patients (73.6%) died without prior appropriate shock.</s><s>Among these, 196 men and 38 women did not experience appropriate shock before death.</s><s>Uncorrected mortality without experiencing prior shock was similar between men and women (P ¼ 0.16).</s></p><p><s>Long-term follow-up for implantable cardioverter-defibrillator therapies First appropriate shock was observed in 266 (23.1%) patients after a follow-up of 4.0 + 2.7 years (annualized rate: 5.8%).</s><s>It was documented in the VF zone in 49% of patients (median cycle length, 235 ms; interquartile range, 210 -258 ms) and in 51% in the VT zone (300 ms; 279 -352 ms).</s><s>Uncorrected annualized appropriate shock rate was 6.3% among men vs. 3.6% among women (P ¼ 0.002).</s><s>Accordingly, there were 32 of 216 women (15%) that did receive appropriate ICD shocks during the long-term follow-up.</s><s>If primary and secondary preventions of SCD were analysed separately, uncorrected annualized ICD shock rate was significantly lower in women in both groups of prevention (2.6 vs. 4.8% p.a., P ¼ 0.033, and 4.9 vs. 7.4% p.a., P ¼ 0.018, respectively).</s></p><p><s>At least one inappropriate shock was delivered in 106 (9.2%) patients, 44 of whom were also treated with appropriate shock.</s><s>Inappropriate shocks were equally distributed between men and women (9.5 vs. 7.9%, P ¼ 0.45).</s><s>Appropriate ATP was noticed in 247 (21.5%) patients, more frequently in men when compared with women (23.3 vs. 13.4%,</s><s>P ¼ 0.001).</s><s>Any appropriate ICD therapy (appropriate ATP or appropriate ICD shock) was observed in 380 (33%) patients, and again more frequently in men (35.4 vs. 22.7%, P ¼ 0.0003).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Univariate and multivariate predictors of mortality</head><p><s>Univariate Cox regression revealed a considerable number of predictors for mortality, as presented in Table <ref type="table" target="#tab_1">2</ref>, left column.</s><s>Sex was not a univariate predictor of mortality, but a statistically nonsignificant trend for better survival of women vs. men was observed, as presented in Table <ref type="table" target="#tab_1">2</ref> and Figure <ref type="figure" target="#fig_0">1</ref>.</s><s>Age, LVEF, renal impairment (eGFR), medication with diuretics, aspirin treatment, peripheral arterial disease (PAD), and chronic obstructive pulmonary disease (COPD) were selected as independent predictors for all-cause mortality in the final Cox model, as presented in Table <ref type="table" target="#tab_1">2</ref>, right columns.</s><s>Sex was not a predictor of mortality in the multivariable model (HR ¼ 1.15, 95% confidence interval (CI) [0.84 -1.58], P ¼ 0.536).</s><s>Unadjusted annualized mortality in women vs. men amounted to 4.6 vs. 5.9% per year (see Figure <ref type="figure" target="#fig_0">1</ref>, HR ¼ 0.768, 95% CI [0.57-1.04],</s><s>P ¼ 0.090).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Death without appropriate shock</head><p><s>Upon univariate Cox regression, a similar number of predictors were revealed as predictors of death without prior appropriate shock, as presented in Table <ref type="table" target="#tab_2">3</ref>, left column.</s><s>The final Cox model identified higher age, renal impairment (eGFR), use of digitalis glycosides or diuretics, PAD, and COPD as independent predictors of death without appropriate shock, as presented in Table <ref type="table" target="#tab_2">3</ref>, right columns.</s><s>Sex category was neither a univariate (P ¼ 0.295) nor a multivariate (P ¼ 0.708) predictor of death without appropriate shock.</s><s>The incidence of death without prior appropriate shock in women vs. men amounted to 3.7 vs. 4.3% per year (see Figure <ref type="figure" target="#fig_1">2</ref>, HR ¼ 0.8, 95% CI [0.6-1.2],</s><s>P ¼ 0.295).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Univariate and multivariate predictors of appropriate implantable cardioverter-defibrillator shock</head><p><s>Univariate Cox regression revealed a significant association of first appropriate shock with male sex, secondary prophylactic ICD indication, prolonged QT interval, oral anticoagulation, treatment with amiodarone, history of atrial fibrillation, and COPD (Table <ref type="table" target="#tab_3">4</ref>, left columns).</s><s>Women were subject to significantly less appropriate ICD shocks (3.6 vs. 6.3% per year, P ¼ 0.002, Figure <ref type="figure" target="#fig_2">3</ref>).</s><s>In the final multivariate Cox model, higher age, female sex, and primary prophylactic indication were identified as independent predictors of fewer appropriate ICD shocks (Table <ref type="table" target="#tab_3">4</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In this large single-centre ICD population with extended follow-up, we identified seven independent predictors of all-cause mortality and three independent predictors of appropriate shock.</s><s>These results highlight that risk factors for mortality do not correspond to those of malignant arrhythmias.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Lower appropriate shock rate in women</head><p><s>As one of the leading results, our data show that female sex was associated with a ≈50% reduced risk of appropriate shocks during the long-term follow-up, but did not influence mortality.</s><s>For the long-term follow-up of ICD patients, this is a novel finding.</s><s>One can conclude that women may derive a smaller benefit from their device if they exhibit less malignant ventricular arrhythmias and mortality is similar after multivariate correction.</s><s>This would not obviate ICD therapy in women but provides new evidence for the hypothesis that individually a higher threshold for ICD indication may be useful in women.</s><s>For instance, this could pertain to the level of left ventricular dysfunction in primary prophylactic indications or the presence of additional risk factors.</s><s>Increased risk for ICD associated complications may further decrease benefit from the device among women <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b18">19</ref> but was not assessed in this study.</s><s>How sex differences translate into clinical arrhythmias and possibly appropriate ICD shocks is not fully studied.</s><s>Arrhythmia susceptibility is influenced by hormonal differences between women and men.</s><s>Among others, there are sex differences in electrophysiological properties such as repolarization, calcium handling, autonomic modulation, and ion channels. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21</ref></s><s>Furthermore, the pathologic substrate is different: gender-based differences in response to myocardial infarction, and with relevance for arrhythmogenesis, have been shown on a molecular level <ref type="bibr" target="#b21">22</ref> and in patients, by mechanism of different vagal tone. <ref type="bibr" target="#b22">23</ref></s><s>In addition, the distribution of ischaemic vs. non-ischaemic cardiomyopathy is not equal between women and men as also observed in our registry (51 vs. 71%).</s></p><p><s>Sex differences in SCD were reported in the Framingham Heart study <ref type="bibr" target="#b23">24</ref> and for out of hospital SCD. <ref type="bibr" target="#b24">25</ref> Several defibrillator trials <ref type="bibr">8 -10</ref> provided evidence to the fact, but were underpowered to prove significance.</s><s>For instance, Zareba et al. <ref type="bibr" target="#b7">8</ref> found identical mortality between women and men, similar ICD benefit, and a 40% lower appropriate shock rate (P ¼ 0.039).</s><s>In contrast, Russo et al. <ref type="bibr" target="#b8">9</ref> found a 32% lower mortality for women vs. men (P ¼ 0.001) but no difference in the incidence of shock and ICD benefit for women.</s><s>Albert et al. <ref type="bibr" target="#b9">10</ref> analysed 458 patients from DEFINITE including 63 women randomized to an ICD.</s><s>Featuring only primary prevention indications and non-ischaemic patients, a 54% reduction of appropriate shocks was found (P ¼ 0.10), a very similar risk reduction as in the current study, although not significant due to the patient number and duration of follow-up.</s><s>In the current study, 219 women were followed for almost 5 years, which is longer than in most prior studies, increasing the power and generalizability of our findings.</s></p><p><s>Gender-focused meta-analyses from the above-mentioned older trials confirmed lower shock rates in women <ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27</ref> but were equivocal on ICD benefit depending on study selection. <ref type="bibr" target="#b27">28</ref></s><s>The largest gender-focused ICD study so far is the Ontario registry providing results in more than 6000 patients. <ref type="bibr" target="#b10">11</ref></s><s>These authors found a 31% lower rate of first appropriate shock in women (P ¼ 0.015) as well as an absent difference in overall survival which is in line with our study.</s><s>The main difference is the short follow-up of only 1 year.</s><s>Wijers et al. <ref type="bibr" target="#b28">29</ref> and Weeke et al. <ref type="bibr" target="#b29">30</ref> provided ICD registry data recently not focusing on sex differences.</s><s>Wijers et al. <ref type="bibr" target="#b28">29</ref> reported a 47% reduction of adjusted mortality for women (P ¼ 0.004), and a 57% reduction of adjusted appropriate shock rate (P ¼ 0.001), whereas Weeke et al. <ref type="bibr" target="#b29">30</ref> reported a significant multivariate HR of 0.33 (95% CI [0.11-0.57]</s><s>for appropriate shocks in women and an insignificant HR for mortality of 0.75 (95% CI [0.49 -1.14]).</s><s>Our study as well as MacFadden et al. <ref type="bibr" target="#b10">11</ref> and Wijers et al. <ref type="bibr" target="#b28">29</ref> combined primary and secondary prophylactic indications, whereas Weeke et al. <ref type="bibr" target="#b29">30</ref> analysed only primary prevention patients.</s><s>Importantly, we found no difference in our main finding between primary and secondary prevention patients.</s><s>Van der Hejden et al. <ref type="bibr" target="#b11">12</ref> published a gender-focused analysis from the Leiden ICD registry in more than 1900 primary prevention patients including 418 women (21%).</s><s>Adjusted all-cause mortality was significantly lower for women (HR ¼ 0.65, 95% CI [0.49 -0.84], P , 0.01) while the rate of appropriate shock showed an adjusted HR of 0.80 (95% CI [0.66 -1.13], P ¼ 0.19).</s><s>Compared with our study, there were somewhat different baseline characteristics such as more frequent CRT-D treatment which may favour women. <ref type="bibr" target="#b30">31</ref></s><s>We chose not to define ATP therapies as endpoints to reflect more malignant arrhythmias in the endpoint; however, results were very similar when adding them.</s><s>Counting appropriate ICD shocks only as a surrogate of arrhythmic mortality in ICD patients may still overestimate the potential risk of arrhythmogenic mortality. <ref type="bibr" target="#b31">32</ref></s><s>However, their unadjusted annualized mortality rates for men (6.8%) and women (5.3%) were in a very similar range as in our study.</s><s>Therefore, the results of van der Heijden et al. <ref type="bibr" target="#b11">12</ref> are not contradictory with our findings or other studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Predictors of mortality</head><p><s>Mortality risk factors identified in our population are confirmatory of the literature in ICD patients.</s><s>Kramer et al. <ref type="bibr" target="#b32">33</ref> validated a mortality risk score in of 2717 ICD patients.</s><s>In multivariate regression, peripheral arterial disease, decreased LVEF, elevated serum creatinine, and higher age remained as independent factors.</s><s>Sex category-as in our study-was not influencing survival.</s><s>Bilchick et al. <ref type="bibr" target="#b33">34</ref> investigated .35</s><s>000 primary prophylactic ICD recipients for mortality predictors and identified age, NYHA status, atrial fibrillation, COPD, kidney disease, LVEF, and diabetes as independent predictors.</s><s>Of note, no shock data were available in the latter two studies.</s><s>The confirmation of mortality factors and HRs in our study is very precise.</s><s>Independent risk factors may be combined to define higher risk groups which was not the purpose of this analysis.</s></p><p><s>The rate of patients never experiencing an appropriate shock in our study was high (75% in men, 85% in women).</s><s>Death without previous appropriate shock was not predicted by sex, but by higher age, decreased renal function, PAD, and COPD.</s><s>These factors are also mortality factors, and coincide with increased morbidity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations</head><p><s>The retrospective design of data collection may confer unknown biases; however, the results for many known variables are confirming other studies proving data validity of this series.</s><s>Implantable cardioverter-defibrillator programming was not uniform over a period of 12 years, and may have influenced the results; however, systematic differences in programming between male and female patients are unlikely.</s><s>However, our ICD technician never changed during the study guaranteeing ICD programming to be as consistent as possible.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>Our data show that after ICD or CRT-D implantation, women receive 50% less appropriate shocks than men but have similar mortality.</s><s>These data may pertain to an individually improved selection of candidates for defibrillator implantation using risk factors for the occurrence of malignant arrhythmias, e.g.</s><s>sex as demonstrated in this study.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc><div><p><s>Figure 1 Cumulative Kaplan -Meier event probability of death according to sex: male (red line) and female (blue line) patients.</s><s>Unadjusted P-value is shown in the figure.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2</head><label>2</label><figDesc><div><p><s>Figure 2 Cumulative Kaplan -Meier event probability of death without prior appropriate ICD shock: male (red line) and female (blue line) patients.</s><s>Unadjusted P-value is shown in the figure.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3</head><label>3</label><figDesc><div><p><s>Figure 3 Cumulative Kaplan-Meier event probability of first appropriate ICD shock: male (red line) and female (blue line) patients.</s><s>Unadjusted P-value is shown in the figure.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="9,246.67,331.37,288.80,301.78" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>3.6% among women.</s><s>† Female sex, older age, and primary prophylactic ICD indication were independent predictors for less appropriate shocks.</s><s>Patient characteristics by sex</s></p></div></figDesc><table><row><cell>Female</cell><cell>Male</cell><cell>P-value</cell></row></table><note><p><s>. ............ ............ ............ ............ ........... ............ ............ ............ ........... ............ ............ ............ ........... ............ .........</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>. .. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . . . .</s><s>.. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .</s><s>.. .. .. .... ............ ............ ............ ............ ........... ............ ............ ............ ........... .....Univariate and multivariate Cox proportional hazards regression (final model) for all-cause mortality</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell cols="3">supraventricular arrhythmias (onset, stability, Biotronik SMART w , Med-</cell></row><row><cell></cell><cell></cell><cell cols="3">tronic Wavelet w , PRLogic w , and Boston Scientific RhythmID w ) were</cell></row><row><cell></cell><cell></cell><cell cols="3">programmed ON where available. Detection zones were repro-</cell></row><row><cell></cell><cell></cell><cell cols="2">grammed in case of VT episodes.</cell><cell></cell></row><row><cell></cell><cell></cell><cell cols="2">Follow-up and endpoints</cell><cell></cell></row><row><cell cols="2">Implantable cardioverter-defibrillator devices from three manufacturers</cell><cell cols="3">All-cause mortality and first appropriate ICD shock were predefined as</cell></row><row><cell cols="2">were implanted (Biotronik, Berlin, Germany; Boston Scientific, Natick,</cell><cell cols="3">endpoints before initiation of the registry. To reflect competing risks of</cell></row><row><cell cols="2">MA, USA, formerly CPI, Guidant, St Paul, MN, USA; and Medtronic</cell><cell cols="3">deaths and shock, the rate of death without prior appropriate shock was</cell></row><row><cell cols="2">Inc., Minneapolis, MN, USA). Implantable cardioverter-defibrillator pro-</cell><cell cols="3">determined. Mortality was assessed based on information from our in-</cell></row><row><cell cols="2">gramming varied over time according to available publications and re-</cell><cell cols="3">stitution, other hospitals, general practitioners, or local authorities.</cell></row><row><cell cols="2">commendations. In general, a programming using two zones was used</cell><cell cols="3">Outpatient ICD follow-up was done every 3 -6 months, or when neces-</cell></row><row><cell cols="2">(ventricular tachycardia, VT zone and ventricular fibrillation, VF zone).</cell><cell cols="3">sary. Episodes stored by the ICD were classified by the treating phys-</cell></row><row><cell cols="2">Ventricular fibrillation was detected for heart rates .210 -230 b.p.m.</cell><cell cols="3">ician at first hand, these were re-evaluated by the investigators (J.S.,</cell></row><row><cell cols="2">Detection counters were set to between 12 and 18 out of 16 and 24</cell><cell cols="3">M.D., and M.Z.). If sustained VT or VF had occurred, ICD treatment</cell></row><row><cell cols="2">beats, 20 of 30 or 30 of 40 settings were not used. Ventricular tachycar-</cell><cell cols="3">was considered appropriate and shocks, particularly first shocks were</cell></row><row><cell cols="2">dia was identified at heart rates .170 b.p.m. and treated by alternating</cell><cell cols="3">documented as endpoints. Appropriate ATP without shock or inappro-</cell></row><row><cell cols="2">burst and ramp trains involving a total of 6 -12 antitachycardia pacing</cell><cell cols="3">priate ICD shocks/ATP were not considered as endpoints. The majority</cell></row><row><cell cols="2">(ATP) cycles. If unsuccessful, shocks of maximal energy followed. For</cell><cell cols="3">of patients was followed exclusively at our ICD clinic (71%). Additional</cell></row><row><cell cols="2">secondary prevention ICDs, programming was individually tiered to</cell><cell cols="3">information about ICD shocks was obtained from outside clinics, treat-</cell></row><row><cell cols="2">documented arrhythmias. Algorithms for improved detection of</cell><cell cols="3">ing cardiologists, or patients by questionnaire or telephone. Retrieval of</cell></row><row><cell></cell><cell>Univariate</cell><cell></cell><cell>Multivariate</cell><cell></cell></row><row><cell></cell><cell>HR [95% CI]</cell><cell>P-value</cell><cell>HR [95% CI]</cell><cell>P-value</cell></row><row><cell>Age (years)</cell><cell>1.058 [1.046-1.071]</cell><cell>&lt;0.001</cell><cell>1.04 [1.03-1.06]</cell><cell>&lt;0.001</cell></row><row><cell>Sex category (male)</cell><cell>1.302 [0.960-1.766]</cell><cell>0.090</cell><cell>1.15 [0.84-1.58]</cell><cell>0.536</cell></row><row><cell>Body mass index (kg/m 2 )</cell><cell>0.977 [0.951-1.003]</cell><cell>0.082</cell><cell></cell><cell></cell></row><row><cell>NYHA functional class</cell><cell>1.587 [1.385-1.819]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>Primary prophylactic indication</cell><cell>1.444 [1.150-1.815]</cell><cell>0.002</cell><cell></cell><cell></cell></row><row><cell>CRT-D</cell><cell>1.515 [1.212-1.893]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>Ischaemic cardiomyopathy</cell><cell>1.501 [1.166-1.932]</cell><cell>0.002</cell><cell></cell><cell></cell></row><row><cell>LVEF (%)</cell><cell>0.972 [0.962-0.983]</cell><cell>&lt;0.001</cell><cell>0.98 [0.97-1.00]</cell><cell>0.025</cell></row><row><cell>Heart rate (b.p.m.)</cell><cell>1.002 [0.998-1.005]</cell><cell>0.336</cell><cell></cell><cell></cell></row><row><cell>QRS duration (ms)</cell><cell>1.007 [1.004-1.011]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>QT interval (ms)</cell><cell>1.003 [1.000-1.005]</cell><cell>0.027</cell><cell></cell><cell></cell></row><row><cell>eGFR (mL/min/1.73 m 2 )</cell><cell>0.979 [0.974-0.984]</cell><cell>&lt;0.001</cell><cell>0.99 [0.99-1.00]</cell><cell>0.009</cell></row><row><cell>Medication</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>ACE inhibitors/ARB</cell><cell>0.997 [0.716-1.388]</cell><cell>0.986</cell><cell></cell><cell></cell></row><row><cell>b-Blocker</cell><cell>0.923 [0.651-1.309]</cell><cell>0.654</cell><cell></cell><cell></cell></row><row><cell>Digitalis</cell><cell>1.507 [1.197-1.898]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>Diuretics</cell><cell>2.872 [2.058-4.008]</cell><cell>&lt;0.001</cell><cell>1.81 [1.29-2.54]</cell><cell>0.002</cell></row><row><cell>MRA</cell><cell>1.012 [0.805-1.273]</cell><cell>0.918</cell><cell></cell><cell></cell></row><row><cell>Aspirin</cell><cell>0.996 [0.792-1.251]</cell><cell>0.971</cell><cell>0.73 [0.58-0.93]</cell><cell>0.029</cell></row><row><cell>Coumadin</cell><cell>1.305 [1.025-1.661]</cell><cell>0.031</cell><cell></cell><cell></cell></row><row><cell>Amiodarone</cell><cell>1.308 [1.016-1.683]</cell><cell>0.037</cell><cell></cell><cell></cell></row><row><cell>Hypertension</cell><cell>1.268 [0.940-1.712]</cell><cell>0.120</cell><cell></cell><cell></cell></row><row><cell>Diabetes</cell><cell>1.587 [1.259-2.001]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>History of atrial fibrillation</cell><cell>1.546 [1.240-1.928]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>Peripheral arterial disease</cell><cell>2.874 [2.149-3.843]</cell><cell>&lt;0.001</cell><cell>2.21 [1.62-3.00]</cell><cell>&lt;0.001</cell></row><row><cell>COPD</cell><cell>1.982 [1.520-2.584]</cell><cell>&lt;0.001</cell><cell>1.48 [1.13-1.94]</cell><cell>0.029</cell></row></table><note><p><s>. ....... ............ ............ ........... ............ ...... AAD, antiarrhythmic drug; AF, atrial fibrillation; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; aspirin, acetylsalicylic acid; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT-D, cardiac resynchronization therapy with defibrillator; eGFR, estimated glomerular filtration rate; HR, hazard ratio; LV, left ventricular; MRA, mineralocorticoid receptor antagonist; NYHA, New York Heart Association.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p><s>, right columns). . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . . .</s><s>Univariate and multivariate Cox proportional hazards regression (final model) for death without appropriate shock</s></p></div></figDesc><table><row><cell></cell><cell>Univariate</cell><cell></cell><cell>Multivariate</cell><cell></cell></row><row><cell></cell><cell>HR [95% CI]</cell><cell>P-value</cell><cell>HR (95% CI)</cell><cell>P-value</cell></row><row><cell>Age (years)</cell><cell>1.063 [1.048-1.078]</cell><cell>&lt;0.001</cell><cell>1.04 [1.03-1.06]</cell><cell>&lt;0.001</cell></row><row><cell>Sex category (male)</cell><cell>1.204 [0.850-1.705]</cell><cell>0.295</cell><cell>1.09 [0.77-1.55]</cell><cell>0.708</cell></row><row><cell>Body mass index (kg/m 2 )</cell><cell>0.972 [0.942-1.003]</cell><cell>0.076</cell><cell></cell><cell></cell></row><row><cell>NYHA functional class</cell><cell>1.711 [1.456-2.011]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>Primary prophylactic indication</cell><cell>1.658 [1.269-2.167]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>CRT-D</cell><cell>1.575 [1.216-2.039]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>Ischaemic cardiomyopathy</cell><cell>1.446 [1.080-1.936]</cell><cell>0.013</cell><cell></cell><cell></cell></row><row><cell>LVEF (%)</cell><cell>0.974 [0.962-0.986]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>Heart rate (b.p.m.)</cell><cell>1.002 [0.998-1.006]</cell><cell>0.298</cell><cell></cell><cell></cell></row><row><cell>QRS duration (ms)</cell><cell>1.007 [1.003-1.011]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>QT interval (ms)</cell><cell>1.001 [0.998-1.004]</cell><cell>0.383</cell><cell></cell><cell></cell></row><row><cell>eGFR (mL/min/1.73 m 2 )</cell><cell>0.977 [0.971-0.983]</cell><cell>&lt;0.001</cell><cell>0.99 [0.98-1.00]</cell><cell>0.008</cell></row><row><cell>Medication</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>ACE inhibitors/ARB</cell><cell>1.035 [0.696-1.541]</cell><cell>0.864</cell><cell></cell><cell></cell></row><row><cell>b-Blocker</cell><cell>0.864 [0.577-1.293]</cell><cell>0.477</cell><cell></cell><cell></cell></row><row><cell>Digitalis</cell><cell>1.558 [1.191-2.038]</cell><cell>0.001</cell><cell>1.47 [1.11-1.94]</cell><cell>0.021</cell></row><row><cell>Diuretics</cell><cell>2.925 [1.967-4.351]</cell><cell>&lt;0.001</cell><cell>1.79 [1.19-2.69]</cell><cell>0.016</cell></row><row><cell>MRA</cell><cell>1.014 [0.776-1.324]</cell><cell>0.920</cell><cell></cell><cell></cell></row><row><cell>Aspirin</cell><cell>1.090 [0.832-1.428]</cell><cell>0.530</cell><cell></cell><cell></cell></row><row><cell>Coumadin</cell><cell>1.268 [0.955-1.683]</cell><cell>0.100</cell><cell></cell><cell></cell></row><row><cell>Amiodarone</cell><cell>1.071 [0.784-1.463]</cell><cell>0.665</cell><cell></cell><cell></cell></row><row><cell>Hypertension</cell><cell>1.229 [0.868-1.741]</cell><cell>0.244</cell><cell></cell><cell></cell></row><row><cell>Diabetes</cell><cell>1.509 [1.150-1.980]</cell><cell>0.003</cell><cell></cell><cell></cell></row><row><cell>History of atrial fibrillation</cell><cell>1.594 [1.233-2.060]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>Peripheral arterial disease</cell><cell>3.474 [2.521-4.788]</cell><cell>&lt;0.001</cell><cell>2.46 [1.76-3.44]</cell><cell>&lt;0.001</cell></row><row><cell>COPD</cell><cell>2.003 [1.476-2.719]</cell><cell>&lt;0.001</cell><cell>1.48 [1.08-2.02]</cell><cell>0.040</cell></row></table><note><p><s>. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .</s><s>.. .. .. .... ............ ............ ............ ............ ........... ............ ............ ............ ........... ............ ............ ............ ........... ............ ...... AAD, antiarrhythmic drug; AF, atrial fibrillation; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; aspirin, acetylsalicylic acid; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT-D, cardiac resynchronization therapy with defibrillator; eGFR, estimated glomerular filtration rate; HR, hazard ratio; LV, left ventricular; MRA, mineralocorticoid receptor antagonist; NYHA, New York Heart Association.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4</head><label>4</label><figDesc><div><p><s>. .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . .</s><s>.. . . . .</s><s>.. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .</s><s>.. .. .. .... ............ ............ ............ ............ ........... ............ ............ ............ ........... ............ ............ ............ ........... ............ ...... Univariate and multivariate Cox proportional hazards regression (final model) for occurrence of the first appropriate shock</s></p></div></figDesc><table><row><cell></cell><cell>Univariate</cell><cell></cell><cell>Multivariate</cell><cell></cell></row><row><cell></cell><cell>HR [95% CI]</cell><cell>P-value</cell><cell>HR [95% CI]</cell><cell>P-value</cell></row><row><cell>Age (years)</cell><cell>0.999 [0.990-1.008]</cell><cell>0.838</cell><cell>0.98 [0.97-0.99]</cell><cell>&lt;0.001</cell></row><row><cell>Sex category (male)</cell><cell>1.773 [1.225-2.567]</cell><cell>0.002</cell><cell>1.94 [1.23-3.04]</cell><cell>0.013</cell></row><row><cell>Body mass index (kg/m 2 )</cell><cell>1.001 [0.975-1.027]</cell><cell>0.968</cell><cell></cell><cell></cell></row><row><cell>NYHA functional class</cell><cell>0.944 [0.823-1.083]</cell><cell>0.411</cell><cell></cell><cell></cell></row><row><cell>Primary prophylactic indication</cell><cell>0.655 [0.512-0.838]</cell><cell>0.001</cell><cell>0.69 [0.52-0.93]</cell><cell>0.043</cell></row><row><cell>CRT-D</cell><cell>0.969 [0.751-1.249]</cell><cell>0.806</cell><cell></cell><cell></cell></row><row><cell>Ischemic cardiomyopathy</cell><cell>1.102 [0.850-1.428]</cell><cell>0.465</cell><cell></cell><cell></cell></row><row><cell>LVEF (%)</cell><cell>0.995 [0.985-1.006]</cell><cell>0.358</cell><cell></cell><cell></cell></row><row><cell>Heart rate (b.p.m.)</cell><cell>0.992 [0.985-1.001]</cell><cell>0.068</cell><cell></cell><cell></cell></row><row><cell>QRS duration (ms)</cell><cell>0.999 [0.995-1.003]</cell><cell>0.734</cell><cell></cell><cell></cell></row><row><cell>QT interval (ms)</cell><cell>1.003 [1.001-1.006]</cell><cell>0.013</cell><cell></cell><cell></cell></row><row><cell>eGFR (mL/min/1.73 m 2 )</cell><cell>0.998 [0.993-1.004]</cell><cell>0.546</cell><cell></cell><cell></cell></row><row><cell>Medication</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>ACE inhibitors/ARB</cell><cell>1.048 [0.722-1.519]</cell><cell>0.807</cell><cell></cell><cell></cell></row><row><cell>b-Blocker</cell><cell>0.901 [0.609-1.334]</cell><cell>0.603</cell><cell></cell><cell></cell></row><row><cell>Digitalis</cell><cell>1.019 [0.781-1.330]</cell><cell>0.889</cell><cell></cell><cell></cell></row><row><cell>Diuretics</cell><cell>1.096 [0.831-1.445]</cell><cell>0.515</cell><cell></cell><cell></cell></row><row><cell>MRA</cell><cell>0.959 [0.749-1.228]</cell><cell>0.739</cell><cell></cell><cell></cell></row><row><cell>Aspirin</cell><cell>0.788 [0.616-1.007]</cell><cell>0.057</cell><cell></cell><cell></cell></row><row><cell>Coumadin</cell><cell>1.391 [1.072-1.804]</cell><cell>0.013</cell><cell></cell><cell></cell></row><row><cell>Amiodarone</cell><cell>1.900 [1.460-2.474]</cell><cell>&lt;0.001</cell><cell></cell><cell></cell></row><row><cell>Hypertension</cell><cell>1.010 [0.741-1.377]</cell><cell>0.950</cell><cell></cell><cell></cell></row><row><cell>Diabetes</cell><cell>1.008 [0.765-1.328]</cell><cell>0.953</cell><cell></cell><cell></cell></row><row><cell>History of atrial fibrillation</cell><cell>1.335 [1.047-1.701]</cell><cell>0.020</cell><cell></cell><cell></cell></row><row><cell>Peripheral arterial disease</cell><cell>0.901 [0.565-1.437]</cell><cell>0.661</cell><cell></cell><cell></cell></row><row><cell>COPD</cell><cell>1.385 [1.010-1.900]</cell><cell>0.043</cell><cell></cell><cell></cell></row></table><note><p><s>AAD, antiarrhythmic drug; AF, atrial fibrillation; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; aspirin, acetylsalicylic acid; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT-D, cardiac resynchronization therapy with defibrillator; eGFR, estimated glomerular filtration rate; HR, hazard ratio; LV, left ventricular; MRA, mineralocorticoid receptor antagonist; NYHA, New York Heart Association.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">appr., appropriate; COPD, chronic obstructive pulmonary disease; CRT-D, cardiac resynchronization therapy with defibrillator; eGFR, estimated glomerular filtration rate; LV, left ventricular; NYHA, New York Heart Association; FU, follow-up.Sex differences in ICD shocks</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Unadjusted P-value is shown in the figure.Sex differences in ICD shocks</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>The research leading to the results has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement n8 602299, EU-CERT-ICD.</s><s>D.C. was supported by a grant of the Swiss National Science Foundation (PP00P3_133681 and PP00P3_159322).</s><s>Funding to pay the Open Access publication charges for this article was provided by the European Community's Seventh Framework Program FP7/2007 -2013 under grant agreement n8 602299, EU-CERT-ICD.</s></p><p><s>Conflict of interest: none declared.</s><s>We implanted a Medtronic Micra Transcatheter Pacing System (TPS) using standard technique, but after cutting the tether, a slight resistance was felt when the tether was pulled back.</s><s>Subsequently, the electrical properties of the system were unacceptable.</s><s>In order to retrieve the TPS, a 3 F snare with a 10 -25 mm loop can be loaded into the delivery system.</s><s>However, this snare was not available.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Retrieval of Medtronic Micra Transcatheter Pacing System after tether removal Christian Gerdes* and Jens Cosedis Nielsen</head><p><s>Instead, the delivery system was retracted, and the introducer was left in the patient.</s><s>A standard steerable sheath (Agilis, St Jude Medical) was introduced into the introducer, but there was a significant blood leak from the introducer's haemostatic valve due to the incongruent sizes.</s><s>Introducing a short 14 F sheath between the introducer and the steerable sheath solved this problem.</s><s>A standard 6 F 20 mm snare kit (Amplatz Goose Neck) subsequently was used to grab the TPS (Figure <ref type="figure">)</ref>, which could be released from the myocardium with a gentle pull and retrieved back into the introducer sheath.</s><s>Echocardiography excluded pericardial effusion, and a new Micra TPS was implanted uneventfully.</s></p><p><s>It is recommended to have a correctly dimensioned snare in stock during TPS implantation.</s><s>In case, for some reason, TPS retrieval is not possible using a small snare, this report describes an alternative strategy.</s></p><p><s>The full-length version of this report can be viewed at: http://www.escardio.org/Guidelines-&amp;-Education/-learning/Clinical-cases/</s><s>Electrophysiology/EP-Case-Reports.</s></p><p><s>Published on behalf of the European Society of Cardiology.</s><s>All rights reserved.</s><s>&amp; The Author 2016.</s><s>For permissions please email: journals.permissions@oup.com.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias</title>
	</analytic>
	<monogr>
		<title level="m">The Antiarrhythmics AVID Investigators</title>
				<imprint>
			<date type="published" when="1997">1997</date>
			<biblScope unit="volume">337</biblScope>
			<biblScope unit="page" from="1576" to="1583" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">A randomized study of the prevention of sudden death in patients with coronary artery disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Buxton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Josephson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Prystowsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hafley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">341</biblScope>
			<biblScope unit="page" from="1882" to="1890" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zareba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Wilber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Cannom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">346</biblScope>
			<biblScope unit="page" from="877" to="883" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Bardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Mark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Poole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Packer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Boineau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">352</biblScope>
			<biblScope unit="page" from="225" to="237" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death</title>
		<author>
			<persName><forename type="first">R</forename><surname>Tung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zimetbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Josephson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1111" to="1121" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction</title>
		<author>
			<persName><forename type="first">I</forename><surname>Goldenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Vyas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="288" to="296" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Koller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wolbers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sticherling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Bucher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Osswald</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="1918" to="1926" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction</title>
		<author>
			<persName><forename type="first">W</forename><surname>Zareba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jackson</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wilber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Ruskin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Mcnitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Electrophysiol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1265" to="1270" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Poole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Mark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Hellkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Electrophysiol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="720" to="724" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Albert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Quigg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Saba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Estes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shaechter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Subacius</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="367" to="372" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Macfadden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Crystal</forename><forename type="middle">E</forename><surname>Krahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Mangat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Healey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Dorian</forename><forename type="middle">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="195" to="203" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Van Der Heijden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thijssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Borleffs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Van Rees</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Hoke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Van Der Velde</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="1244" to="1249" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Levey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Coresh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Greene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Marsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Kusek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="766" to="772" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">A proportional hazards model for the subdistribution of a competing risk</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Fine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Gray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Stat Assoc</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="496" to="509" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Multiple imputation of missing blood pressure covariates in survival analysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Van Buuren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Boshuizen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Knook</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stat Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="681" to="694" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Multivariate Imputation by Chained Equations in R</title>
		<author>
			<persName><forename type="first">S</forename><surname>Van Buuren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Groothuis-Oudshoorn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Stat Softw</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1" to="67" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Pocock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Ariti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Mcmurray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maggioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kober</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Squire</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1404" to="1413" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">Modeling Survival Data: Extending the Cox Model</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Therneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Grambsch</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2000">2000</date>
			<publisher>Springer</publisher>
			<biblScope unit="page" from="44" to="47" />
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
	<note>Stratified Cox models</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Peterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Daugherty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Vidaillet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Heidenreich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Curtis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="1078" to="1084" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Gender differences and risk of ventricular tachycardia or ventricular fibrillation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Haigney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zareba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Nasir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcnitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mcadams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Gentlesk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart Rhythm</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="180" to="186" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Drici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Burklow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Haridasse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">I</forename><surname>Glazer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Woosley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="1471" to="1474" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Female mice lacking estrogen receptor beta display prolonged ventricular repolarization and reduced ventricular automaticity after myocardial infarction</title>
		<author>
			<persName><forename type="first">T</forename><surname>Korte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fuchs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Arkudas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Geertz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gardiwal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="2282" to="2290" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Gender difference in autonomic and hemodynamic reactions to abrupt coronary occlusion</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Airaksinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ikaheimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Linnaluoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">U</forename><surname>Tahvanainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">V</forename><surname>Huikuri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="301" to="306" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Sudden coronary death in women</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Kannel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'agostino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Cobb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="205" to="212" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Sex-related differences in the presentation and outcome of out-of-hospital cardiopulmonary arrest: a multiyear, prospective, population-based study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Wigginton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Pepe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Bedolla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Detamble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Atkins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="S131" to="136" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ghanbari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dalloul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Daccarett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Saba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>David</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="1500" to="1506" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Santangeli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pelargonio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dello</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Casella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bisceglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bartoletti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart Rhythm</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="876" to="882" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Sex differences in ICD benefit</title>
		<author>
			<persName><forename type="first">L</forename><surname>Bergau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Seegers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zabel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Electrocardiol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="869" to="873" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Wijers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Y</forename><surname>Van Der Kolk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Tuinenburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Doevendans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Meine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neth Heart J</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="274" to="283" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register</title>
		<author>
			<persName><forename type="first">P</forename><surname>Weeke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Johansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Jorgensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Videbaek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Europace</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1150" to="1157" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Women have better long-term prognosis than men after cardiac resynchronization therapy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Zabarovskaja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gadler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Braunschweig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stahlberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hornsten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Linde</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Europace</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1148" to="1155" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Use and misuse of surrogate outcomes in arrhythmia trials</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Connolly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="764" to="766" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Kallinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Crusan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Hodge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart Rhythm</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="42" to="46" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Bilchick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Stukenborg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kamath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1647" to="1655" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<monogr>
		<title/>
		<idno type="DOI">10.1093/europace/euv444</idno>
		<imprint>
			<date type="published" when="2016-02-06">6 February 2016</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
